532523:BOM
Biocon Ltd
350,00 INR
arrow_downward
−0,43%(−1,50) 1D
16. lis, 15:30:00 GMT+5:30 · INR
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za 532523...
Otvori
352,95 INR
Najviša
352,95 INR
Najniža
348,10 INR
Trž. kap.
568,79 mlr.
Prosj. kol.
692,61 tis.
Količina
668,34 tis.
Dividenda
0,14 %
Kvartalna dividenda
0,13 INR
Datum nakon isplate dividende
3. srp 2026.
P/E omjer
103,62
52-tjed. najviša
447,00 INR
52-tjed. najniža
337,95 INR
EPS
3,38 INR
Dionice u optjecaju
600,00 mil.
Broj djelatnika
16 tis.
Otvori
352,95 INR
Najviša
352,95 INR
Najniža
348,10 INR
Trž. kap.
568,79 mlr.
Prosj. kol.
692,61 tis.
Količina
668,34 tis.
Dividenda
0,14 %
Kvartalna dividenda
0,13 INR
Datum nakon isplate dividende
3. srp 2026.
P/E omjer
103,62
52-tjed. najviša
447,00 INR
52-tjed. najniža
337,95 INR
EPS
3,38 INR
Dionice u optjecaju
600,00 mil.
Broj djelatnika
16 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
Financije.hr
·
prije 1 dan
Wall Street pred otvaranjem: Rotacija iz tehnologije jača, Dow preuzima vodstvo
Opening Bell Daily
·
prije 55 minuta
Stock market after midterms: S&P 500 up all 19 times
Simply Wall Street
·
prije 1 sat
Aura Minerals (NasdaqGS:AUGO) Shares Just Moved, So What Is Going On?
FinanceFeeds
·
prije 55 minuta
The Nasdaq Index Just Had Its Worst Week Since June - and Netflix, Tesla and Meta Report Next
Profil
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
Biocon Ltd – informacije
Glavni izvršni direktorShreehas P Tambe
Zaposlenici16,4 tis.
Osnovano29. stu 1978.
SjedišteBangalore, Karnataka, Indija
Sektor-
Web-lokacijabiocon.com